Aquatic HIIT Trial for Parkinson's Disease Shows Potential Benefits
A randomized trial is assessing the impact of an 8-week aquatic HIIT program on patients with Parkinson's disease.
Asset / Drug
Drug and asset intelligence for Aquatic with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.